Concepedia

Max W. Sung

MW

53

Publications

6K

Citations

33

H-Index

1988

Active since

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Tisch Cancer Institute

Tisch Hospital

Kindai University

Eisai (United States)

Max W. Sung is an author at Icahn School of Medicine at Mount Sinai specializing in radiation oncology, oncology, and medicine.

ORCID

Top concepts

Publications per year

1988–2024

53

Publications

53

Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma

Richard S. Finn, Masafumi Ikeda, Andrew X. Zhu et al. · Journal of Clinical Oncology · 2020 · 1.1K citations · Full text

The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies

Junko Ozao‐Choy, Ge Ma, Johnny Kao et al. · Cancer Research · 2009 · 528 citations · Full text

, , +17

Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis

Sasan Roayaie, Jonathan D. Schwartz, Max W. Sung et al. · Liver Transplantation · 2004 · 460 citations

Long-Term Results With Multimodal Adjuvant Therapy and Liver Transplantation for the Treatment of Hepatocellular Carcinomas Larger Than 5 Centimeters

Sasan Roayaie, Jason S. Frischer, Sukru Emre et al. · Annals of Surgery · 2002 · 385 citations · Full text

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 364 citations

, , +10

Rows per page

1–5 of 53